Literature DB >> 9852811

Health care utilization by patients with temporomandibular joint disorders.

D G Shimshak1, M C DeFuria.   

Abstract

The claims data base of a large New England managed care organization was used to compare the health care utilization patterns of patients with TMJ disorders to non-TMJ subjects. Inpatient, outpatient and psychiatric claims data were examined over a wide range of diagnostic categories. Age and sex adjusted results showed that, overall, patients with TMJ disorders were greater utilizers of health care services and had higher associated costs than non-TMJ subjects. For some of the major diagnostic categories, such as nervous, respiratory, circulatory, and digestive, the inpatient and outpatient claims differences in utilization and costs were as large as 3 to 1. For only one diagnostic category, pregnancy and childbirth, were utilization and costs greater for non-TMJ subjects than TMJ patients. The psychiatric claims for TMJ patients exhibited differences that were at least twice as large as those for the non-TMJ subjects.

Entities:  

Mesh:

Year:  1998        PMID: 9852811     DOI: 10.1080/08869634.1998.11746056

Source DB:  PubMed          Journal:  Cranio        ISSN: 0886-9634            Impact factor:   2.020


  3 in total

1.  Are temporomandibular disorder symptoms and diagnoses associated with pubertal development in adolescents? An epidemiological study.

Authors:  Christian Hirsch; Julia Hoffmann; Jens C Türp
Journal:  J Orofac Orthop       Date:  2012-01-12       Impact factor: 1.938

2.  Back and neck pain: A comparison between acute and chronic pain-related Temporomandibular Disorders.

Authors:  Jack Botros; Mervyn Gornitsky; Firoozeh Samim; Zovinar der Khatchadourian; Ana Miriam Velly
Journal:  Can J Pain       Date:  2022-07-01

3.  Developing Effective and Efficient care pathways in chronic Pain: DEEP study protocol.

Authors:  Justin Durham; Matthew Breckons; Vera Araujo-Soares; Catherine Exley; Jimmy Steele; Luke Vale
Journal:  BMC Oral Health       Date:  2014-01-21       Impact factor: 2.757

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.